✨
AI Summary
- Concerns raised about FDA's Commissioner's National Priority Voucher Program.
- Potential legal issues and resource demands of releasing unapproved product action packages.
- Discussion on FDA's CNPV program and its implications.
Guests on This Episode
DG
Derrick Gingery
8 podcast appearances
NH
Nielsen Hobbs
8 podcast appearances
SS
Sue Sutter
8 podcast appearances